NCT07322783
- Conditions
- EGFR Positive Non-small Cell Lung Cancer, MET Amplification
- Locations
-
- Qingdao Central Hospital Qingdao, China
Clinical trial condition
EGFR Positive Non-small Cell Lung Cancer
Explore clinical trials studying EGFR Positive Non-small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.
11 public trials
3 recruiting studies
EGFR Positive Non-small Cell Lung Cancer trial results
NCT04900935
- Conditions
- ALK-positive Non-small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +14 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
NCT05037331
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
- National University Hospital Singapore
Not Yet Recruiting
Firmonertinib in Perioperative Treatment of Resectable Stage II-IIIB EGFR-mutated Lung Adenocarcinoma
NCT07622706
- Conditions
- EGFR Positive Non-small Cell Lung Cancer, NSCLC, Neoadjuvant Therapy
- Locations
-
Not specified
Not Yet Recruiting
Firmonertinib 160 mg in Patients With EGFR-Mutant Advanced NSCLC Demonstrating SD After 8 Week Induction With Firmonertinib 80 mg
NCT07298148
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
Not specified
Completed
Firmonertinib in the Treatment of EGFR(+) NSCLC Patients With Central Nervous System Metastasis
NCT07239102
- Conditions
- Central Nervous System Metastasis, Central Nervous System Neoplasms, EGFR Positive Non-small Cell Lung Cancer, +7 more
- Locations
-
- Li Xiaoyan Beijing, Beijing Municipality, China
NCT04105153
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Thoraxklinik-Heidelberg gGmbH - Universitätsklinikum Heidelberg Heidelberg, Germany
NCT02729298
- Conditions
- Adnexal Diseases, Advanced Solid Tumors, BRAF-Mutated Melanoma, +26 more
- Locations
-
- Mayo Clinic Arizona Phoenix, Arizona, United States
- HonorHealth Research Institute Scottsdale, Arizona, United States
- University of Colorado Denver Denver, Colorado, United States
- US Oncology - Rocky Mountain Cancer Centers, LLP (RMCC) Denver, Colorado, United States
Active, Not Recruiting
Radiation During Osimertinib Treatment: a Safety and Efficacy Cohort Study
NCT05089916
- Conditions
- EGFR Positive Non-small Cell Lung Cancer, NSCLC, Oligoprogression
- Locations
-
- LMU Klinikum der Universität München München, Germany
Active, Not Recruiting
A Study of APG-1252 Plus Osimertinib(AZD9291) in EGFR TKI Resistant NSCLC Patients
NCT04001777
- Conditions
- EGFR Positive Non-small Cell Lung Cancer
- Locations
-
- Sun-Yat Sen University Cancer Center Guangzhou, Guangdong, China
- Henan Provincial people's Hospital Zhengzhou, Henan, China
- First Hospital of Jilin University Changchun, Jilin, China
- Jilin Provincial Cancer Hospital Changchun, Jilin, China